Nrf2 deficiency in a Friedreich's ataxia animal model and potential therapies

被引：0
|
作者：
Cortopassi, G. A. [1 ]
Sahdeo, S. [1 ]
Shan, Y. [1 ]
Schoenfeld, R. A. [1 ]
Pook, M. A. [2 ]
Hayashi, G. [1 ]
机构：
[1] Univ Calif Davis, Davis, CA 95616 USA
[2] Brunel Univ, London, England
来源：
JOURNAL OF NEUROCHEMISTRY | 2013年 / 125卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：178 / 178
页数：1
相关论文
共 50 条
  • [1] The Nrf2 induction prevents ferroptosis in Friedreich's Ataxia
    La Rosa, Piergiorgio
    Petrillo, Sara
    Turchi, Riccardo
    Berardinelli, Francesco
    Schirinzi, Tommaso
    Vasco, Gessica
    Lettieri-Barbato, Daniele
    Fiorenza, Maria Teresa
    Bertini, Enrico S.
    Aquilano, Katia
    Piemonte, Fiorella
    REDOX BIOLOGY, 2021, 38
  • [2] Omaveloxolone: an activator of Nrf2 for the treatment of Friedreich ataxia
    Profeta, Victoria
    McIntyre, Kellie
    Wells, McKenzie
    Park, Courtney
    Lynch, David R.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2023, 32 (01) : 5 - 16
  • [3] Targeting NRF2 for the Treatment of Friedreich's Ataxia: A Comparison among Drugs
    Petrillo, Sara
    D'Amico, Jessica
    La Rosa, Piergiorgio
    Bertini, Enrico Silvio
    Piemonte, Fiorella
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (20)
  • [4] Nrf2 Agonist Omaveloxolone Improves Cardiac Function in Mice With Friedreich's Ataxia
    Figueroa, Francisco
    Salinas, Lili
    Montgomery, Claire
    Thai, Phung
    Chiamvimonvat, Nipavan
    Cortopassi, Gino
    Dedkova, Elena N.
    CIRCULATION, 2022, 146
  • [5] The NRF2 Signaling Network Defines Clinical Biomarkers and Therapeutic Opportunity in Friedreich's Ataxia
    La Rosa, Piergiorgio
    Bertini, Enrico Silvio
    Piemonte, Fiorella
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (03)
  • [6] Emerging therapies in Friedreich's Ataxia
    Zesiewicz, Theresa A.
    Hancock, Joshua
    Ghanekar, Shaila D.
    Kuo, Sheng-Han
    Dohse, Carlos A.
    Vega, Joshua
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2020, 20 (12) : 1215 - 1228
  • [7] Emerging therapies in Friedreich's ataxia
    Aranca, Tanya V.
    Jones, Tracy M.
    Shaw, Jessica D.
    Staffetti, Joseph S.
    Ashizawa, Tetsuo
    Kuo, Sheng-Han
    Fogel, Brent L.
    Wilmot, George R.
    Perlman, Susan L.
    Onyike, Chiadi U.
    Ying, Sarah H.
    Zesiewicz, Theresa A.
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2016, 6 (01) : 49 - 65
  • [8] Frataxin Deficiency Leads to Defects in Expression of Antioxidants and Nrf2 Expression in Dorsal Root Ganglia of the Friedreich's Ataxia YG8R Mouse Model
    Shan, Yuxi
    Schoenfeld, Robert A.
    Hayashi, Genki
    Napoli, Eleonora
    Akiyama, Tasuku
    Carstens, Mirela Iodi
    Carstens, Earl E.
    Pook, Mark A.
    Cortopassi, Gino A.
    ANTIOXIDANTS & REDOX SIGNALING, 2013, 19 (13) : 1481 - 1493
  • [9] Frataxin deficiency increases cyclooxygenase 2 and prostaglandins in cell and animal models of Friedreich's ataxia
    Hayashi, Genki
    Shen, Yan
    Pedersen, Theresa L.
    Newman, John W.
    Pook, Mark
    Cortopassi, Gino
    HUMAN MOLECULAR GENETICS, 2014, 23 (25) : 6838 - 6847
  • [10] Impaired Nuclear Nrf2 Translocation Undermines the Oxidative Stress Response in Friedreich Ataxia
    Paupe, Vincent
    Dassa, Emmanuel P.
    Goncalves, Sergio
    Auchere, Francoise
    Loenn, Maria
    Holmgren, Arne
    Rustin, Pierre
    PLOS ONE, 2009, 4 (01):
12345